Posttransplant recurrence of primary glomerulonephritis

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 12, 2010, Pages 2363-2372

  Ponticelli, Claudio ^a   Glassock, Richard J ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; CEPHALOSPORIN; COMPLEMENT FACTOR H; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ECULIZUMAB; FIBRINOGEN; FRESH FROZEN PLASMA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; MANGANESE SUPEROXIDE DISMUTASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPASE A2 RECEPTOR; PODOCIN; PREDNISONE; PROTEIN A; RAPAMYCIN; RITUXIMAB; STEROID; SYNAPTOPODIN; TACROLIMUS; UNINDEXED DRUG;

DISEASE COURSE; DONOR; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PLASMAPHERESIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RECURRENT DISEASE; REVIEW; RISK FACTOR; T LYMPHOCYTE;

GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY TRANSPLANTATION; RECURRENCE;

EID: 78650364370     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06720810     Document Type: Review

References (127)

1. Glassock RJ, Feldman D, Reynolds ES, Dammin GJ, Merrill JP: Human renal isografts: A clinical and pathologic analysis. Medicine (Baltimore) 47: 411-454, 1968
2. Hariharan S, Adams MB, Brennan DC, Davis CL, First RM, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F: Recurrent and de novo glomerular disease after renal transplantation. A report from the Renal Allograft Disease Registry (RADR). Transplantation 68: 635-641, 1999 (Pubitemid 29453439)
3. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadbans J: Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347: 103-109, 2002 (Pubitemid 34753480)
4. Novak J, Julian B, Tomana M, Mestecky J: IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol 28: 78-87, 2008 (Pubitemid 351310031)
5. Barratt J, Eitner F, Feehally J, Floege J: Immune complex formation in IgA nephropathy: A case of the "right" antibodies in the "wrong" place at the "wrong" time? Nephrol Dial Transplant 24: 3620-3623, 2009
6. Furness PN, Roberts ISD, Briggs JD: Recurrent glomerular disease in transplants. Transplant Proc 34: 242, 2002
7. Ponticelli C, Traversi L, Banfi G: Renal transplantation in patients with IgA mesangial glomerulonephritis. Pediatr Transplant 8: 334-338, 2004 (Pubitemid 39062114)
8. Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y: Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63: 2286-2294, 2003 (Pubitemid 36605844)
9. Hariharan S, Savin VJ: Recurrent and de novo disease after renal transplantation: A report from the Renal Allograft Disease Registry. Pediatr Transplant 8: 349-350, 2004 (Pubitemid 39062117)
10. Lim EC, Chia D, Terasaki PI: Studies of sera from IgA nephropathy patients to explain high kidney graft survival. Hum Immunol 32: 81-86, 1991
11. Jeong HJ, Park SK, Cho YM, Kim MS, Kim YS, Choi J, Kim SI, Lim BJ: Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy. Hum Pathol 39: 1511-1518, 2008
12. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG: Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 65: 1053-1060, 1998 (Pubitemid 28208423)
13. Soler MJ, Mir M, Rodriguez E, Orfila A, Munne A, Vázquez S, Lloveras J, Puig JM: Recurrence of IgA nephropathy and Henoch-Schoenlein purpura after kidney transplantation: Risk factors and graft survival. Transplant Proc 37: 3705-3709, 2005 (Pubitemid 43015140)
14. Chacko B, George JT, Neelakantan N, Korula A, Chakko JK: Outcomes of renal transplantation in patients with immunoglobulin A nephropathy in India. J Postgrad Med 53: 92-95, 2007 (Pubitemid 46808808)
15. Andresdottir MB, Haasnoot GW, Persijn GG, Claas FH: HLA-B8, DR3: A new risk factor for graft failure after renal transplantation in patients with underlying immunoglobulin A nephropathy. Clin Transplant 23: 660-665, 2009
16. Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A: Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 60: 1948-1954, 2001
17. McDonald SP, Russ GR: Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. Transplantation 27, 759-762, 2006
18. Choy BY, Chan TM, Lo SK, Lo WK, Lai KN: Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 18: 2399-2404, 2003 (Pubitemid 37336832)
19. Ng YS, Vathsala A, Chew ST, Chiang GS, Woo KT: Long-term outcome of renal allografts in patients with immunoglobulin A nephropathy. Med J Malaysia 62: 109-113, 2007 (Pubitemid 47203389)
20. Benabdallah L, Rerolle JP, Peraldi MN, Noël LH, Bruneel MF, Carron PL, Morelon E, Kreis H: An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy. Am J Kidney Dis 40: E20, 2002
21. Kowalewska J, Yuan S, Sustento-Reodica N, Nicosia RF, Smith KD, Davis CL, Alpers CE: IgA nephropathy with crescents in kidney transplant recipients. Am J Kidney Dis 45: 167-175, 2005 (Pubitemid 40038058)
22. Chailimpamontree W, Dmitrienko S, Li G, Balshaw R, Magil A, Shapiro RJ, Landsberg D, Gill J, Keown PA; Genome Canada Biomarkers in Transplantation Groupe: Probability, predictors, and prognosis of posttransplantation glomerulonephritis. J Am Soc Nephrol 20: 843-851, 2009
23. Floege J: Recurrent IgA nephropathy after renal transplantation. Semin Nephrol 24: 287-291, 2004 (Pubitemid 38685996)
24. Andresdottir MB, Haasnot GW, Doxiadis II, Persjin GG, Claas FH: Exclusive characteristics of graft survival and risk factors in recipients of immunoglobulin A nephropathy: A retrospective analysis of registry data. Transplantation 80: 1012-1018, 2005
25. Wang AYM, Lai FM, Yu AWY Lam PK, Chow KM, Choi PC, Lui SF, Li PK: Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 38: 588-596, 2001
26. Kim YS, Moon JI, Jeong HJ, Kim MS, Kim SI, Choi KH, Lee HY, Han DS, Park K: Live donor renal allograft in endstage renal failure patients from immunoglobulin A nephropathy. Transplantation 71: 233-238, 2001
27. Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y: Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Clin Transplant 19[Suppl 14]: 41-48, 2005
28. Tang Z, Ji SM, Chen DR Wen JQ, Liu ZH, Li LS: Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation. Ren Fail 30: 611-616, 2008
29. Berthoux F, El Deeb S, Mariat C, Diconne E, Laurent B, Thibaudin L: Anti-thymocyte globulin (ATG) induction therapy and disease recurrence in renal transplant recipients with primary IgA nephropathy. Transplantation 85: 1505-1507, 2008
30. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J: Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119: 1666-1677, 2009
31. Glassock RJ: Analyzing antibody activity in IgA nephropathy. J Clin Invest 119: 1450-1452, 2009
32. Coppo R, Feehally J, Glassock RJ: IgA nephropathy at two score and one. Kidney Int 77: 181-186, 2010
33. Mestecky J, Suzuki H, Yanagihara T, Moldoveneanu Z, Tomana M, Matousovic C, Julian BA, Novak J: IgA nephropathy: Current views of immune complex formation. Contrib Nephrol 157: 58-63, 2007
34. Mulay AV, van Walraven C, Knoll GA: Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. Am J Transplant 9: 804-811, 2009
35. Oka K, Imai E, Moriyama T, Akagi Y, Ando A, Hori M, Okuyama A, Toki K, Kyo M, Kokado Y, Takahara S: A clinicopathological study of IgA nephropathy in renal transplant recipients: Beneficial effect of angiotensin-converting enzyme inhibitor. Nephrol Dial Transplant 15: 689-695, 2000
36. Hiremath S, Fergusson D, Doucette S, Mulay AV, Knoll GA: Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence. Am J Transplant 7: 2350-2360, 2007
37. Kennoki T, Ishida H, Yamaguchi Y, Tanabe K: Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation. Transplantation 88: 935-941, 2009
38. Couser W: Recurrent glomerulonephritis in the renal allograft: An update of selected areas. Exp Clin Transplant 3: 283-288, 2005
39. Newstead CG: Recurrent disease in renal transplants. Nephrol Dial Transplant 18[Suppl 6]: 68-74, 2003
40. Tejani A, Stablein DH: Recurrence of focal segmental glomerulosclerosis posttransplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 2[Suppl]: S258-S263, 1992
41. Fine RN: Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol 22: 496-502, 2007
42. Carraro M, Caridi G, Bruschi M, Artero M, Bertelli R, Zennaro C, Musante L, Candiano G, Perfumo F, Ghiggeri GM: Serum glomerular permeability activity in patients with podocin mutation (NPHS2) and steroid resistant nephrotic syndrome. J Am Soc Nephrol 13: 1946-1952, 2002
43. Fuentes GM, Meseguer CG, Carrion AP, Hijosa MM, Garcia-Pose A, Melgar AA, Torres MN: Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation. Pediatr Nephrol 25: 529-534, 2010
44. Baum MA: Outcomes after renal transplantation for FSGS in children. Pediatr Transplant 8: 329-333, 2004
45. Pardon A, Audard V, Caillard S, Moulin B, Desvaux D, Bentaarit B, Remy P, Sahali D, Roudot-Thoraval F, Lang P, Grimbert P: Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 21: 1053-1059, 2006
46. Moroni G, Gallelli B, Quaglini S, Banfi G, Montagnino G, Messa P: Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis. Transpl Int 23: 208-216, 2010
47. Ponticelli C: Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation. Nephrol Dial Transplant 25: 25-31, 2010
48. Canaud G, Dion D, Zuber J, Gubler MC, Sberro R, Thervet E, Snanoudj R, Charbit M, Salomon R, Martinez F, Legendre C, Noel LH, Niaudet P: Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: Course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant 25: 1321-1328, 2010
49. Baum MA, Stablein DM, Panzarino VM Tejani A, Harmon WE, Alexander SR: Loss of living donor renal allograft advantage in children with focal segmental glomerulosclerosis. Kidney Int 59: 328-333, 2001
50. Abbott KC, Sawyers ES, Oliver JD III, Ko CW, Kirk AD, Welch PG, Peters TG, Agodoa LY: Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 237: 366-373, 2001
51. Cibrik DM, Kaplan B, Campbell DA, Meier-Kriesche HU: Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis. Am J Transplant 3: 64-67, 2003
52. Weber S, Gribouval O, Esquivel EL, Morinière V, Tête MJ, Legendre C, Niaudet P, Antignac C: NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 66: 571-579, 2004
53. Vincenti F, Ghiggeri GM: New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 5: 1179-1185, 2005
54. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334: 878-883, 1996
55. Dantal J, Godfrin Y, Koll R, Perretto S, Naulet J, Bouhours JF, Soulillou JP: Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 9: 1709-1715, 1998
56. Rea R, Smith C, Sandhu K, Kwan J, Tomson C: Successful transplant of a kidney with focal segmental glomerulosclerosis. Nephrol Dial Transplant 16: 416-417, 2001
57. Savin VJ, McCarthy ET, Sharma M: Permeability factors in focal segmental glomerulosclerosis. Semin Nephrol 23: 147-160, 2003
58. Trachtman H, Greenbaum LA, McCarthy ET, Sharma M, Gauthier BG, Frank R, Warady B, Savin VJ: Glomerular permeability activity: Prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome. Am J Kidney Dis 44: 604-610, 2004
59. Canaud G, Martinez F, Noel LH, Mamzer MF, Niaudet P, Legendre C: Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients. Transplant Rev (Orlando) 24: 121-128, 2010
60. Ingulli E, Tejani A: Incidence, treatment and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children: A single center experience. Transplantation 51: 401-405, 1991
61. Salomon R, Gagnadoux MF, Niaudet P: Intravenous cyclosporine therapy in recurrent nephrotic syndrome after transplantation in children. Transplantation 75: 810-814, 2003
62. Raafat RH, Kalia A, Travis LB, Diven SC: High-dose cyclosporine therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 44: 50-56, 2004
63. Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P: The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14: 931-938, 2008
64. Canaud G, Zuber J, Sberro R, Royale V, Anglicheau D, Snanoudj R, Gaha K, Thervet E, Lefrère F, Cavazzana- Calvo M, Noël LH, Méjean A, Legendre C, Martinez F: Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: A pilot study. Am J Transplant 9: 1081-1086, 2009
65. Ohta T, Kawaguchi H, Hattori M, Komatsu Y, Akioka Y, Nagata M, Shiraga H, Ito K, Takahashi K, Ishikawa N, Tanabe K, Yamaguchi Y, Ota K: Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 71:628-633, 2001
66. Gohh RY, Yango AF, Morrissey PE, Monaco AP, Gautam A, Sharma M, McCarthy ET, Savin VJ: Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 5: 2907-2912, 2005
67. Apeland T, Hartmann A: Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation. Nephrol Dial Transplant 23: 2091-2094, 2008
68. Meyer TN, Thaiss F, Stahl RA: Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl Int 20:1066-1071, 2008
69. Westphal S, Hansson S, Mjörnstedt L, Mölne J, Swerkersson S, Friman S: Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab. Transplant Proc 38: 2659-2660, 2006 (Pubitemid 44693649)
70. Hristea D, Hadaya K, Marangon N, Buhler L, Villard J, Morel P, Martin PY: Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int 20: 102-105, 2007
71. Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L: Use of Rituximab in focal glomerulosclerosis relapses after renal transplantation. Transplantation 88: 417-420, 2009
72. Sakai K, Takasu J, Nihei H, Yonekura T, Aoki Y, Kawamura T, Mizuiri S, Aikawa A: Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient. Clin Transplant 24[Suppl 22]: 60-65, 2010
73. Kamar N, Faguer S, Esposito L, Guitard J, Nogier MB, Durand D, Rostaing L: Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Clin Nephrol 67: 250-254, 2007 (Pubitemid 46605375)
74. El-Firjani A, Hoar S, Karpinski J, Bell R, Deschenes MJ, Knoll GA: Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy. Nephrol Dial Transplant 23: 425, 2008 (Pubitemid 351767399)
75. Yabu JM, Ho B, Scandling JD, Vincenti F: Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant. 8: 222-227, 2008
76. Rodríguez-Ferrero M, Ampuero J, Anaya F: Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis. Transplant Proc 41: 2406-2408, 2009
77. Vinai M, Waber P, Seikaly MG: Recurrence of focal segmental glomerulosclerosis in renal allograft: An in-depth review. Pediatr Transplant 14: 314-325, 2010
78. Hogan SL, Muller KE, Jennette JC, Falk RJ: A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 25: 862-875, 1995
79. Ponticelli C, Passerini P: Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy? J Nephrol 23: 156-163, 2010
80. Crosson JT, Wathen RL, Raij L, Andersen RC, Andersen WR: Recurrence of membranous nephropathy after renal transplantation. Arch Int Med 135: 1101-1106, 1975
81. Petersen VP Olsen TS, Kissmeyer-Nielsen F, Bohman SO, Hansen ES, Skov PE, Solling K: Late failure of human renal transplant. An analysis of transplant disease and graft failure among 125 recipients surviving for one to eight years. Medicine 54: 45-69, 1975
82. Morzycka M, Croker BP, Seigler HF, Tisher CC: Evaluation of recurrent glomerulonephritis in kidney allografts. Am J Med 72: 588-598, 1982 (Pubitemid 12089333)
83. Berger BE, Vincenti F, Biava C, Amend WJ Jr, Feduska N, Salvatierra O Jr: De novo and recurrent membranous glomerulopathy following kidney transplantation. Transplantation 35: 315-319, 1983 (Pubitemid 13117458)
84. Obermiller LE, Hoy WE, Eversole M, Sterling WA: Recurrent membranous glomerulonephritis in two renal transplants. Transplantation 40: 100-102, 1985 (Pubitemid 15006770)
85. Bansal VK, Kozeny GA, Fresco R, Vertuno LL, Hano JE: De novo membranous nephropathy following renal transplantation between conjoint twins. Transplantation 41: 404-406, 1986
86. Montagnino G, Colturi C, Banfi G, Aroldi A, Tarantino A, Ponticelli C: Membranous nephropathy in cyclosporine-treated renal transplant recipients.Transplantation 47: 725-727, 1989.
87. Truong L, Gelfand J, D'Agati V, Tomaszewski J, Appel G, Hardy M, Pirani CL: De novo membranous nephropathy in renal allograft. A report of ten cases and review of the literature. Am J Kidney Dis 14: 131-141, 1989
88. Monga G, Mazzucco G, Basolo B, Quaranta S, Motta M, Segoloni G, Amoroso A: Membranous glomerulonephritis (MGN) in transplanted kidneys: Morphologic investigation on 256 renal allografts. Mod Pathol 6: 249-258, 1993
89. Josephson MA, Spargo B, Hollandsworth DO, Thistlewait MD: The recurrence of membranous glomerulopathy in a renal transplant recipient: Case report and literature review. Am J Kidney Dis 24: 873-878, 1994
90. Innes A, Woodrow G, Boyd SM, Beckingham IJ, Morgan AG: Recurrent membranous nephropathy in successive renal transplants. Nephrol Dial Transplant 9: 323-325, 1994
91. Heidet L, Gagnadoux ME, Beziau A, Niaudet P, Broyer M, Habib R: Recurrence of de novo membranous glomerulonephritis on renal grafts. Clin Nephrol 41: 314-318, 1994
92. Couchoud C, Pouteil-Noble C, Colon S, Touraine JL: Recurrence of membranous nephropathy after renal transplantation. Transplantation 59: 1275-1279, 1995
93. Odorico JS, Knechtle SJ, Rayhill SC, Pirsch JD, D'Alessandro AM, Belzer FO, Sollinger HW: The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 61: 228-234, 1996
94. Marcen R, Mampaso F, Teruel JL, Rivera ME, Orofino L, Navarro-Antolin J, Ortuño J: Membranous nephropathy: Recurrence after kidney transplantation. Nephrol Dial Transplant 11: 1129-1133, 1996
95. Cosyns JP, Couchoud C, Pouteil-Noble C, Squifflet JP, Pirson Y: Recurrence of membranous nephropathy after renal transplantation: Probability, outcome and risk factors. Clin Nephrol 50: 144-153, 1998
96. Lazowski P, Sablay LB, Glicklich D: Recurrent crescentic membranous nephropathy in two successive renal transplants: Association with choroidal effusions and retinal detachment. Am J Nephrol 18: 146-150, 1998
97. Poduval RD, Josephson MA, Javaid B: Treatment of de novo and recurrent membranous nephropathy in renal transplant patients. Semin Nephrol 23: 392-399, 2003
98. Chan KW, Chan GS, Tang S: Glomerular pathology of allograft kidneys in Hong Kong. Transplant Proc 37: 4293-4296, 2005
99. Carneiro-Roza F, Medina-Pestana JO, Moscoso-Solorzano G, Franco M, Ozaki K, Mastroianni-Kirsztajn G: Initial response to immunosuppressive and renoprotective treatment in posttransplant glomerulonephritis. Transplant Proc 38: 3491-3497, 2006
100. Gallon L, Chhabra D: Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient. Am J Transplant 6: 3017-3021, 2006
101. Dabade TS, Grande JP, Norby SM, Fervenza FC, Cosio FG: Recurrent idiopathic membranous nephropathy after kidney transplantation: A surveillance biopsy study. Am J Transplant 8: 1318-1322, 2008
102. Liebl R, Krämer BK: Recurrence and spontaneous remission of membranous nephropathy after renal transplantation. Clin Nephrol 70: 419-421, 2008
103. Weclawiak H, Ribes D, Guilbeau-Frugier C, Touchard G, Kamar N, Mehrenberger M, Modesto A, Rostaing L: Relapse of membranous glomerulopathy after kidney transplantation: Sustained remittance induced by rituximab. Clin Nephrol 69: 373-376, 2008
104. Sirimongkolrat T, Premasathian N, Vongwiwatana A, Limsrichamrern S, Cheunsuchon B, Vasuvattakul S: Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: A case report. Transplant Proc 40: 2440-2441, 2008
105. El Kossi M, Harmer A, Goodwin J, Wagner B, Shortland J, Angel C, McKane W: De novo membranous nephropathy associated with donor-specific alloantibody. Clin Transplant 22: 124-127, 2008
106. Aline-Fardin A, Rifle G, Martin L, Justrabo E, Bour JB, D'Athis P, Tanter Y, Mousson C: Recurrent and de novo membranous glomerulopathy after kidney transplantation. Transplant Proc 41: 669-671, 2009
107. El-Zoghby ZM, Grande JP, Fraile MG, Norby SM, Fervenza FC, Cosio FG: Recurrent idiopathic membranous nephropathy: Early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant 9: 2800-2807, 2009
108. Sprangers B, Lefkowitz GI, Cohen SD, Stokes MB, Valeri A, Appel GB, Kunis CL: Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation. Clin J Am Soc Nephrol 5: 790-797, 2010
109. Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschênes G, Ronco PM: Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346: 2053-2060, 2002
110. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
111. Prunotto M, Carnevali ML, Candiano G, Murtas C, Bruschi M, Corradini E, Trivelli A, Magnasco A, Petretto A, Santucci L, Mattei S, Gatti R, Scolari F, Kador P, Allegri L, Ghiggeri GM: Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2. J Am Soc Nephrol 21: 507-519, 2010
112. Stahl R, Hoxha E, Fechner K: PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. N Engl J Med 363: 496-498, 2010
113. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P: Rituximab for idiopathic membranous nephropathy. Lancet 360: 923-924, 2002
114. Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC: Rituximab treatment of idiopathic membranous nephropathy. Kidney Int 73: 117-125, 2008 (Pubitemid 350273646)
115. Glassock RJ: Membranoproliferative glomerulonephritis. In: Evidence-Based Nephrology, edited by Molony DA, Craid JC. London, Wiley-Blackwell, 2009:183-196
116. Lorenz EC, Sethi S, Leung N, Dispenzieri A, Fervenza F, Cosio FG: Recurrent membranoproliferative glomerulonephritis after kidney transplantation. Kidney Int 77: 721-728, 2010
117. Braun MC, Stablein DM, Hamiwka LA, Bell L, Bartosh SM, Strife CF: Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: the North American Pediatric Renal Transplant Cooperative Study Experience. J Am Soc Nephrol 16: 2225-2233, 2005
118. Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ: Severity of primary MPGN, rather than MPGN type determines renal survival and post-transplant recurrence risk. Kidney Int 69: 504-511, 2006 (Pubitemid 43164442)
119. Morales JM: Hepatitis C virus infection and renal disease after renal transplantation. Transplant Proc 36: 760-762, 2004 (Pubitemid 38534383)
120. Lien YH, Scott K: Long term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation. Am J Kidney Dis 35: 539-543, 2000 (Pubitemid 30124088)
121. Wu J, Jaar BG, Briggs WA, Choi MJ, Kraus ES, Racusen LC, Atta MG, Samaniego MD: High-dose mycophenolate mofetil in the treatment of post-transplant glomerular disease in the allograft: A case series. Nephron Clin Pract 98: c61-66, 2004 (Pubitemid 39482566)
122. Pickering MC, Cook HT: Translational mini-review series on complement factor H: Renal diseases associated with complement factor H: Novel insights form humans and animal. Clin Exp Immunol 151: 210-230, 2008
123. Smith RJ, Alexander J, Barlow PN, Botto M, Cassavant TL, Cook HT, de Córdoba SR, Hageman GS, Jokiranta TS, Kimberling WJ, Lambris JD, Lanning LD, Levidiotis V, Licht C, Lutz HU, Meri S, Pickering MC, Quigg RJ, Rops AL, Salant DJ, Sethi S, Thurman JM, Tully HF, Tully SP, van der Vlag J, Walker PD, Würzner R, Zipfel PF; Dense Deposit Disease Focus Group: New approaches to the treatment of dense deposit disease. J Am Soc Nephrol 18: 2447-2456, 2007
124. Andresdottir MB: Recommendations for the diagnosis and treatment of dense deposit disease. Nat Clin Pract Nephrol 4: 68-69, 2008 (Pubitemid 351185769)
125. Licht C, Weyersberg A, Heinen S, Stapenhorst L, Devenge J, Beck B, Waldherr R, Kirschfink M, Zipfel PF, Hoppe B: Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor domain 15. Am J Kidney Dis 45: 415-421, 2005 (Pubitemid 40431070)
126. Saland JM, Ruggenenti P, Remuzzi G and the Consensus Study Group: Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol 20: 940-949, 2009
127. Ponticelli C, Villa M, Cesana B, Montagnino G, Tarantino A: Risk factors for late kidney allograft failure. Kidney Int 62: 1848-1854, 2002